Anzeige
Erschienen in:
28.11.2017 | Ankle
Ultrasound measurements of Achilles tendon length using skin markings are more reliable than extended-field-of-view imaging
Erschienen in: Knee Surgery, Sports Traumatology, Arthroscopy | Ausgabe 7/2018
Einloggen, um Zugang zu erhaltenAbstract
Purpose
Elongation of the Achilles tendon has been associated with poorer function in patients treated for ruptures. This has led to the development of various ultrasound-based measurements, and the purpose of the present study was to compare the reliability of three ultrasound-based measuring procedures.
Methods
Twenty healthy individuals (40 tendons) were assessed by two testers at two occasions, 12 weeks apart. The tendon length was measured from the calcaneal insertion to the mid-sagittal muscle tendon junction (MTJ) using skin markings or extended-field-of-view (EFOV) imaging, or from the calcaneal insertion to the distal medial MTJ using skin markings. Test–retest and inter-tester reliability as well as side-to-side length differences were assessed for all three procedures.
Results
Test–retest intraclass correlation coefficients (ICCs) for measurements from the mid-sagittal MTJ using EFOV imaging and skin markings, and from the distal medial MTJ using skin markings were 0.83, 0.90 and 0.96 for tester 1 and 0.87, 0.91 and 0.96 for tester 2, respectively. The corresponding inter-tester ICCs were 0.85, 0.91 and 0.96. Side-to-side lengths were significantly different for measurements from the mid-sagittal MTJ and the distal medial MTJ using skin markings, with mean differences of 0.3 and 0.4 cm, respectively.
Conclusions
Test–retest and inter-tester ICCs were excellent for all three measuring procedures, however, the use of skin markings provided consistently better agreement and reliability compared to EFOV images. The best agreement and highest ICCs were achieved for measurements from the distal medial MTJ, but side-to-side length differences warrant caution when contralateral measurements are used to evaluate tendon elongation.
Level of evidence
III.